Exercise is not a cure, but it’s something most people can do during their treatment to help their recovery, and reduce the chance of cancer recurring once they’ve finished treatment.

Community-treated HER2-low mBC patients were older (mean 63.5 years), with impaired performance status (22.7%) and comorbidities (39.3%), suggesting broader clinical complexity than trial cohorts.

Social media prompts stating that other users flagged a post as false could help slow the spread of cancer misinformation ...

People living with cancer can access pioneering exercise treatment at a new centre in Hull. Yorkshire Cancer Research has taken space at Cherry Tree Court in the city centre, which has recently been ...

The new treatment uses the unique biology of the cancer itself to guide radiotherapy delivery, even in tumors that are in motion.

A woman from Somerset is urging others to trust their instincts and to continue pushing for medical appointments after an ...

Real-world community study finds Enhertu in HER2-low metastatic breast cancer has trial-like discontinuation rates; ILD remains key toxicity.

It’s demoralizing to know the final word in a cancer treatment plan can come from a profit-driven decision made in an insurer’s office instead of a doctor.

As the world pauses to mark International Women's Day on March 8, the conversation around women’s empowerment must also ...

A new kind of blood test promises to find cancer early – sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different can ...

A former reality television star has spoken out about a recent health scare. Teddi Mellencamp revealed that she was recently ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...